Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rewinding RX vs TeleDocs360

Rewinding RX
Graded #340

Higher grade

vs+4.299999999999997
TeleDocs360
Graded #444

Lower grade

The verdict

Rewinding RX takes it — 59.5/100 to 55.2/100.

Rewinding RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rewinding RX is a longevity-focused telehealth platform that frames compounded GLP-1 therapy within a broader biological-age-reversal program alongside NAD+ and functional-medicine protocols.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRewinding RX +18
45
27
Dose & formulationTeleDocs360 +35
40
75
Clinical oversightRewinding RX +1
85
84
Labs & monitoringRewinding RX +1
53
52
FulfillmentRewinding RX +27
87
60
Contract termsRewinding RX +41
61
20
Rewinding RX · left barTeleDocs360 · right bar

The numbers

MetricRewinding RXTeleDocs360
WeighScore59.5/10055.2/100
GradeCC
Scorecard rank#340#444
SemaglutideNot disclosed$399/mo (compounded)
TirzepatideNot disclosed$399/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Rewinding RX

Graded #340 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer — uncommon transparency
  • MD-only physician network ('never a physician assistant or nurse')
  • All-50-state coverage with physician state-licensing matching
  • Corporate entity disclosed (Rewinding RX Ltd.)

Where it loses points

  • Pricing not shown — fully gated behind sign-up
  • Pharmacy partner not named (only generic 503A/503B references)
  • Medical director / clinical leadership not disclosed
  • Governing law, arbitration venue, and corporate address not disclosed
  • Tirzepatide not listed on the homepage (semaglutide only confirmed)
TeleDocs360

Graded #444 · C

Strengths

  • Transparent $399/month base pricing for standard dosing
  • Multiple GLP-1 options including injectable and oral semaglutide
  • Cash-pay model with HSA/FSA card acceptance
  • Fast online intake and 24-hour prescription approval
  • Cancel anytime between shipments

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • No individual provider credentials or board certifications shown
  • Higher doses increase cost

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard